I Am Just a Support Teacher

The press conference lasted until the afternoon.

The main reason is that some state media reporters want to confirm whether what Tian Jiajia said is true.

For this reason, CCTV reporters also connected well-known AIDS experts to ask Tian Jiajia questions.

They are afraid that this matter will be reported without proving its authenticity. If what Tian Jiajia said is false by then, China will be embarrassed in front of the whole world.

But even so, after the interview, many official media did not dare to assume that Tian Jiajia had really developed a specific drug for AIDS just based on the experimental video and experimental data provided by Tian Jiajia.

So after the press conference, some unofficial media reported on the incident one after another, while most of the mainstream official media, such as CCTV, only reported that Tian Jiajia might have developed a special drug for AIDS. Further investigation is required.

The official media reported this matter relatively conservatively, but even so, the news that Tian Jiajia had developed a specific AIDS drug spread all over the Chinese Internet in one night.

However, abroad, this matter did not cause any waves.

After several foreign media reported the incident, more media immediately came forward to refute it.

In the end, several media outlets that reported the news also came forward to apologize, saying that the news was not true.

In such a situation, anyone with a little intelligence would be able to guess that these companies must have touched the interests of some people, and then they were suppressed.

The day after Yang Xin and Tian Jiajia held a press conference, officials contacted Tian Jiajia, wanting to investigate and confirm the authenticity of the specific AIDS drug.

The country attaches great importance to this matter. There are more than 40 million AIDS patients in the world, and China only has 1 million. If China has a specific drug for AIDS, then this drug will not only be a drug, but will rise to the level of politics. level.

Just like artemisinin, this drug has played a big role in maintaining friendly relations between China and Africa.

On the second day of the press conference, Tian Jiajia returned to the capital again.

In the next period of time, she needs to work with a group of AIDS experts to do the animal experiments again.

As long as it can prove the effect of specific drugs on animals, as Tian Jiajia said at the press conference, the country will immediately approve Tian Jiajia's drugs for human clinical trials.

At that time, the country will also open a special green channel for review, so that this drug will be launched as soon as possible.

It is good for medicines to be on the market as soon as possible, but the raw materials for making AIDS specific medicines are very scarce-such as the high-altitude herbs and the medicinal materials produced in Siberia.

Therefore, the most urgent task is to artificially cultivate the raw materials as soon as possible during the drug review stage.

In this way, the raw materials for the production of this drug will only be available after the drug is approved for marketing.

On Yang Xin's side, he vetoed the idea of ​​letting Tian Jiajia become a shareholder of He Xin Pharmaceutical Company and let He Xin Pharmaceutical Company invest in the medicinal material planting base.

After all, Hexin Pharmaceutical Company has other shareholders. If Tian Jiajia takes this medicine as a shareholder, wouldn't it be cheaper for others?

So the two decided that he and Tian Jiajia would each contribute one billion yuan to establish a new pharmaceutical company.

In the new pharmaceutical company, Tian Jiajia holds 60% of the shares with the achievement of AIDS specific medicine, and Yang Xin takes the remaining 40% of the shares with the achievement of neutralizing the poison of Changshan and investing one billion. shares.

The prescription for neutralizing Changshan's toxicity was redeemed by Yang Xin from the system mall by spending 300 points, so this is his personal achievement, separate from Tian Jiajia's research achievement.

After all, one yard counts for one yard, so he can't just give Tian Jiajia this achievement for nothing.

If he hadn't exchanged this thing, Tian Jiajia wouldn't have had a few years to research the specific medicine for AIDS.

Therefore, it is only natural that he bought 40% of the company's shares by exchanging 300 points.

————

After the press conference, many media reported on Tian Jiajia's development of a specific AIDS drug.

However, the authenticity of the specific AIDS drug is still under investigation, and all netizens across the country are looking forward to the results of the expert group's investigation.

This investigation was carried out by several national biological laboratories. Tian Jiajia provided finished AIDS specific drugs to several biological laboratories, and then the laboratories would find HIV-infected macaques and chimpanzees to test the drugs.

If the medicine is real and effective, then I believe there will be results soon.

In the anticipation of netizens, in less than half a month, good news came from a national key biological laboratory.

In the experiment, three rhesus monkeys and two chimpanzees who were slightly infected with HIV, after half a month of different doses of drugs, the HIV in their bodies was completely killed.

After the results of this laboratory came out, good news came from several other laboratories soon, and finally proved that this specific AIDS drug is real and effective.

The next day, the Central News Network officially released the news to the people of the whole country.

At the same time, the People's Daily also released the news on major platforms. Congratulations to Tian Jiajia for her achievements and thanks for bringing hope to AIDS patients.

As the two largest official media spoke out, other media immediately began to reprint or issue their own press releases.

On this day, countless media reported the news one after another.

"Teacher, the Food and Drug Administration has approved the clinical trial of this drug."

On this day, Tian Jiajia called Yang Xin and told him good news.

"That's good, do you continue to follow up the clinical trial or hand it over to the company?" Yang Xin asked Tian Jiajia.

The two had established a three-port pharmaceutical company, and Yang Xin asked He Qingqing to directly recruit a group of people from major pharmaceutical companies to form the company's team.

The president of this company is also held by He Qingqing for the time being, and will be handed over to a professional manager after the company is on the right track.

"Leave it to the company. The drug has been researched. As long as there are no major problems, I am not going to intervene. I am going to continue researching new drugs." Tian Jiajia said to Yang Xin.

"Research on new drugs? Which aspect?" Yang Xin asked curiously.

"Let's study tumors!"

Tian Jiajia said: "Currently, among the five terminal diseases, rheumatoid, leukemia, and AIDS have cure methods and drugs, but there are still many cancers that cannot be cured, so I want to start with cancer." Tian Jiajia said to Yang Xin.

"Okay, you have ambition, the teacher supports you." Yang Xin encouraged.

Speaking of cancer, Mama Yang's lung cancer was cured by Yang Xin, but that kind of cancer treatment method is too expensive, and most people can't cure it at all.

And that method later proved that the success rate is very low, and it was mostly luck that Yang's mother was able to save her, so this method of treatment cannot be promoted on a large scale.